Literature DB >> 6862997

Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide.

A Niederwieser, B Steinmann, U Exner, F Neuheiser, U Redweik, M Wang, S Rampini, U Wendel.   

Abstract

A boy, aged 7 months, of consanguineous parents presented with an acute onset of vomiting, fever, nonketotic hypoglycemia and acidosis and died from cardiac arrest after ventricular fibrillation. He had hepatomegaly and echocardiographically a non-obstructive cardiomyopathy. Autopsy was not allowed. After birth the child had suffered from a severe respiratory distress syndrome, transient metabolic acidosis and had a sweaty feet odour. Later on, development was retarded with a severe muscular hypotonia. Post mortem, numerous unusual organic acids were found in high concentrations in urine, e.g. dicarbonic acids, 2-hydroxyisobutyric, isovaleric, 3-hydroxyisovaleric acid, N-acyl glycines, isovalerylglutamic acid and sarcosine. This pattern indicated deficiencies of several acyl-Co A dehydrogenases in the metabolism of leucine, isoleucine, valine, lysine, short-chain fatty acids and sarcosine. This could be confirmed using cultured skin fibroblasts which were shown to degrade the corresponding labeled substrates insufficiently to 14CO2. It is assumed that the functional multiple acyl-Co A dehydrogenation deficiency is caused by a deficiency of a common link in the electron transfer system of these dehydrogenases which is inherited autosomal recessively in this family. Among the 12 patients reported, 7 died within the first 5 days of age.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6862997

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  19 in total

1.  Sarcosinaemia in a retarded, amaurotic child.

Authors:  A C Sewell; M Krille; I Wilhelm
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

2.  Striatal degeneration in glutaric acidaemia type II.

Authors:  C W Chow; F E Frerman; S I Goodman; G K Brown; J J Pitt; D M Danks
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Biosynthesis of electron transfer flavoprotein in a cell-free system and in cultured human fibroblasts. Defect in the alpha subunit synthesis is a primary lesion in glutaric aciduria type II.

Authors:  Y Ikeda; S M Keese; K Tanaka
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

4.  Symptoms and signs in organic acidurias.

Authors:  N J Brandt
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Prenatal diagnosis of the organic acidurias.

Authors:  L Sweetman
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

6.  Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities.

Authors:  M Duran; J B de Klerk; S K Wadman; H R Scholte; R P Beekman; F G Jennekens
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

7.  Complementation analysis of fatty acid oxidation disorders.

Authors:  A Moon; W J Rhead
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

8.  Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency).

Authors:  S I Goodman; F E Frerman
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

9.  Molecular characterization of variant alpha-subunit of electron transfer flavoprotein in three patients with glutaric acidemia type II--and identification of glycine substitution for valine-157 in the sequence of the precursor, producing an unstable mature protein in a patient.

Authors:  Y Indo; R Glassberg; I Yokota; K Tanaka
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

Review 10.  Primary (genetic) cardiomyopathies in infancy. A survey of possible disorders and guidelines for diagnosis.

Authors:  A Kohlschütter; G Hausdorf
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.